2021 FUTURES: Gene Therapy & Gene Editing Symposium
Information and updates on the gene therapy and gene editing landscape from experts in the field.
**We experienced a technical issue during this session. Please reach out with questions to Futures@CureDuchenne.org if needed.

Beth Belluscio, MD, PhD
Global Clinical Lead, Rare Neurological Disorders
Pfizer




Alison Mcvie-Wylie, PhD
Vice President, Disease Area Executive, DMD
Vertex Pharmaceutical



Matthew Pletcher, PhD
Division Head of Gene Therapy Research & Technical Operations
Astellas Gene Therapies

Deanna Tucker, PharmD
Senior Medical Science Liaison
Sarepta Therapeutics

